1. Home
  2. ASBP vs KITT Comparison

ASBP vs KITT Comparison

Compare ASBP & KITT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASBP
  • KITT
  • Stock Information
  • Founded
  • ASBP 2021
  • KITT 2014
  • Country
  • ASBP United States
  • KITT United States
  • Employees
  • ASBP N/A
  • KITT N/A
  • Industry
  • ASBP Biotechnology: Pharmaceutical Preparations
  • KITT Industrial Machinery/Components
  • Sector
  • ASBP Health Care
  • KITT Industrials
  • Exchange
  • ASBP Nasdaq
  • KITT Nasdaq
  • Market Cap
  • ASBP 18.9M
  • KITT 16.4M
  • IPO Year
  • ASBP N/A
  • KITT N/A
  • Fundamental
  • Price
  • ASBP $0.24
  • KITT $1.42
  • Analyst Decision
  • ASBP
  • KITT
  • Analyst Count
  • ASBP 0
  • KITT 0
  • Target Price
  • ASBP N/A
  • KITT N/A
  • AVG Volume (30 Days)
  • ASBP 2.6M
  • KITT 5.3M
  • Earning Date
  • ASBP 11-24-2025
  • KITT 11-12-2025
  • Dividend Yield
  • ASBP N/A
  • KITT N/A
  • EPS Growth
  • ASBP N/A
  • KITT N/A
  • EPS
  • ASBP N/A
  • KITT N/A
  • Revenue
  • ASBP N/A
  • KITT $3,082,232.00
  • Revenue This Year
  • ASBP N/A
  • KITT $2,936.06
  • Revenue Next Year
  • ASBP N/A
  • KITT N/A
  • P/E Ratio
  • ASBP N/A
  • KITT N/A
  • Revenue Growth
  • ASBP N/A
  • KITT N/A
  • 52 Week Low
  • ASBP $0.20
  • KITT $1.24
  • 52 Week High
  • ASBP $15.80
  • KITT $54.36
  • Technical
  • Relative Strength Index (RSI)
  • ASBP 36.55
  • KITT 30.55
  • Support Level
  • ASBP $0.32
  • KITT $1.42
  • Resistance Level
  • ASBP $0.47
  • KITT $3.43
  • Average True Range (ATR)
  • ASBP 0.06
  • KITT 0.34
  • MACD
  • ASBP -0.01
  • KITT -0.07
  • Stochastic Oscillator
  • ASBP 8.27
  • KITT 8.22

About ASBP Aspire Biopharma Holdings Inc. Common Stock

Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tracts.

About KITT Nauticus Robotics Inc.

Nauticus Robotics Inc develops fully electric autonomous robotic solutions for subsea applications. The company's business model includes using robotic systems for service, selling vehicles and components, and licensing related software to both the commercial and defense business sectors. The company's addressable markets include upstream, midstream, and downstream oil and gas, defense, offshore renewables, seafloor telecommunications, aquaculture, port security, oceanographic research, and subsea mining.

Share on Social Networks: